clinicaltrials_resource:7ad4a63b7933cbbf19efea4509e90dc1
Efficacy and Safety of IVIG-L in ITP Patients [clinicaltrials:NCT00151840]Double Blind Atorvastatin Amlodipine Study [clinicaltrials:NCT00159718]Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years [clinicaltrials:NCT00161785]Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR [clinicaltrials:NCT00161824]Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004 [clinicaltrials:NCT00161837]FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years [clinicaltrials:NCT00161876]clinicaltrials:NCT00191308Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder [clinicaltrials:NCT00195559]Comparison of Immunosuppression Protocols After LTx in Children [clinicaltrials:NCT00195988]The Role of Reactive Oxygen Species in Ischaemia-Reperfusion Injury of the Transplanted Kidney [clinicaltrials:NCT00204178]Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation [clinicaltrials:NCT00204191]Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702 [clinicaltrials:NCT00205478]Efficacy Study of Dysport® in the Treatment of Anal Fissure. [clinicaltrials:NCT00210444]Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients [clinicaltrials:NCT00211952]Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer [clinicaltrials:NCT00217815]Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients [clinicaltrials:NCT00239070]Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis [clinicaltrials:NCT00301665]Latanoprost Versus Fotil [clinicaltrials:NCT00304785]clinicaltrials:NCT00306527clinicaltrials:NCT00309751Stem Cell Therapy to Improve Myocardial Function in Patients With Acute Myocardial Infarction [clinicaltrials:NCT00316381]An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression [clinicaltrials:NCT00319709]Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine [clinicaltrials:NCT00344318]clinicaltrials:NCT00344370Ocular Surface Changes in Patients With Cystic Fibrosis [clinicaltrials:NCT00345280]Risedronate in Postmenopausal Women With Low Bone Density [clinicaltrials:NCT00351091]Simvastatin Therapy in Women With Polycystic Ovary Syndrome. [clinicaltrials:NCT00365638]clinicaltrials:NCT00366548Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study [clinicaltrials:NCT00371098]Polish-Italian-Hungarian RAndomized ThrombEctomy Trial [clinicaltrials:NCT00377650]European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry [clinicaltrials:NCT00378391]EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI [clinicaltrials:NCT00394368]Chronic and Acute Effects of Smoking on the Left and Right Ventricular Relaxation in Young Healthy Smokers [clinicaltrials:NCT00395928]Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial. [clinicaltrials:NCT00396513]Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®) [clinicaltrials:NCT00413387]clinicaltrials:NCT00452452Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic Sclerosis [clinicaltrials:NCT00453752]Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea [clinicaltrials:NCT00455598]Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule [clinicaltrials:NCT00460486]Wyeth Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants [clinicaltrials:NCT00464945]
authority [clinicaltrials_vocabulary:authority]
clinicaltrials_resource:7ad4a63b7933cbbf19efea4509e90dc1
Bio2RDF identifier
7ad4a63b7933cbbf19efea4509e90dc1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7ad4a63b7933cbbf19efea4509e90dc1
identifier
clinicaltrials_resource:7ad4a63b7933cbbf19efea4509e90dc1